Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Slap On The Wrist? FTC Puts Out Media Guidance On Weight Loss Ad Claims

This article was originally published in The Tan Sheet

Executive Summary

A series of actions unveiled by the Federal Trade Commission to combat false advertising claims for weight loss products includes a set of media guidelines to help prevent dissemination of deceptive ads

You may also be interested in...



NAD alerts FDA, FTC to SlimForce 7 ad

After failing to reach Toronto-based SlimForce 7, which markets a weight-loss product as a supplement under the same name, the Council of Better Business Bureaus unit refers the firm to FDA, the Federal Trade Commission and the Competition Bureau of Canada. NAD said Aug. 10 that a magazine ad claims SlimForce 7 "is a treatment aimed at all those who can't lose weight," enables loss of 11 pounds in one week and modifies the body's metabolism. The claims qualify as "too good to be true" under FTC's reference guide for bogus weight-loss claims (1"The Tan Sheet" Dec. 15, 2003). NAD said SlimForce 7 did not respond to multiple communication attempts

NAD alerts FDA, FTC to SlimForce 7 ad

After failing to reach Toronto-based SlimForce 7, which markets a weight-loss product as a supplement under the same name, the Council of Better Business Bureaus unit refers the firm to FDA, the Federal Trade Commission and the Competition Bureau of Canada. NAD said Aug. 10 that a magazine ad claims SlimForce 7 "is a treatment aimed at all those who can't lose weight," enables loss of 11 pounds in one week and modifies the body's metabolism. The claims qualify as "too good to be true" under FTC's reference guide for bogus weight-loss claims (1"The Tan Sheet" Dec. 15, 2003). NAD said SlimForce 7 did not respond to multiple communication attempts

NAD alerts FDA, FTC to SlimForce 7 ad

After failing to reach Toronto-based SlimForce 7, which markets a weight-loss product as a supplement under the same name, the Council of Better Business Bureaus unit refers the firm to FDA, the Federal Trade Commission and the Competition Bureau of Canada. NAD said Aug. 10 that a magazine ad claims SlimForce 7 "is a treatment aimed at all those who can't lose weight," enables loss of 11 pounds in one week and modifies the body's metabolism. The claims qualify as "too good to be true" under FTC's reference guide for bogus weight-loss claims (1"The Tan Sheet" Dec. 15, 2003). NAD said SlimForce 7 did not respond to multiple communication attempts

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096281

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel